Diabetes Blood Test Distributor GlycoMark Agrees
Outcome
OIG enforcement action against Diabetes Blood Test Distributor GlycoMark Agrees for false claims. Penalty: $195,000.
Details
Diabetes Blood Test Distributor GlycoMark Agrees — OIG Enforcement (2026)
OIG took enforcement action against Diabetes Blood Test Distributor GlycoMark Agrees in 2026 involving false claims violations in the Healthcare General sector.
Penalty: $195,000
Violation types: False Claims
Entity type: Healthcare Provider
Penalty type: Settlement
Source: Diabetes Blood Test Distributor GlycoMark Agrees To Pay $195,000 To Settle False Claims Act Allegations
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works